Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New pathogens for respiratory infections

R Cosentini1, F Blasi

  • 1Divisione di Medicina dUrgenza, Pad. Pasini, IRCCS Ospedale Maggiore, Milan, Italy.

Current Opinion in Pulmonary Medicine
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.

Frontiers in endocrinology·2023
Same author

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis.

Vaccine·2023
Same author

Surgical management of colon cancer in ulcerative colitis patients with orthotopic liver transplant for primary sclerosing cholangitis. A systematic review.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2023
Same author

Staging accuracy of MRI of the prostate with special reference to the influence of the time of last ejaculation on the detection of seminal vesicle invasion.

Clinical radiology·2023
Same author

Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death.

Scientific reports·2022
Same author

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis.

Pulmonology·2022

New pathogens and antimicrobial resistance drive severe lower respiratory tract infections. Hantavirus, Chlamydia pneumoniae, and resistant Streptococcus pneumoniae pose significant global health threats, necessitating novel treatments and prevention strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Lower respiratory tract infections (LRTI) present a significant global health burden, exacerbated by emerging pathogens and increasing antimicrobial resistance.
  • Key pathogens of concern include Hantaviruses, Chlamydia pneumoniae, and penicillin-resistant Streptococcus pneumoniae.
  • These pathogens contribute to both acute, high-mortality conditions and chronic respiratory diseases.

Purpose of the Study:

  • To highlight the epidemiological impact of specific emerging and resistant pathogens causing LRTI.
  • To underscore the clinical characteristics and risk factors associated with Hantavirus pulmonary syndrome.
  • To emphasize the growing role of Chlamydia pneumoniae in community-acquired pneumonia and chronic lung diseases, and the rise of antibiotic-resistant Streptococcus pneumoniae.

Related Experiment Videos

Main Methods:

  • Review of recent international research and case reports on Hantavirus, Chlamydia pneumoniae, and Streptococcus pneumoniae.
  • Analysis of epidemiological data, mortality rates, and identified risk factors for Hantavirus pulmonary syndrome.
  • Synthesis of findings on the prevalence and clinical associations of Chlamydia pneumoniae and antimicrobial resistance patterns of Streptococcus pneumoniae.

Main Results:

  • Hantavirus pulmonary syndrome has a high mortality rate (52%) with risk factors including rodent exposure and peridomestic activities.
  • Chlamydia pneumoniae is a leading cause of community-acquired pneumonia and implicated in chronic obstructive pulmonary disease and asthma.
  • Penicillin-resistant Streptococcus pneumoniae strains are increasing significantly.

Conclusions:

  • The study highlights the urgent need for new therapeutic agents to combat emerging and resistant respiratory pathogens.
  • Enhanced prevention programs are crucial to mitigate the impact of these infections.
  • Continued research into novel treatments and diagnostic strategies is essential for managing LRTI effectively.